Burden of disease and treatment patterns for psoriatic arthritis in Finland: a nationwide real-world evidence study
Patients experienced increasing absenteeism before first bDMARD initiation, indicating an unmet need at treatment initiation. This suggests that earlier medication initiation could be beneficial, as a bDMARD switch with the bDMARD armamentarium available during the study period did not fully address growing absenteeism.
Authors
- Liisa Ukkola‐Vuoti (ORCID: https://orcid.org/0000-0002-0770-361X)
- Anton Klåvus (ORCID: https://orcid.org/0000-0003-2612-0230)
- Iiro Toppila
- Dan Nordström (ORCID: https://orcid.org/0000-0002-3661-6072)
- Lauri Veijalainen (ORCID: https://orcid.org/0000-0003-1707-2265)
- Petri Juhani Kristian Elo
Institutions
- Helsinki University Hospital (FI)
- Medibeacon (United States) (US)
- Orion Corporation (Finland) (FI)
- Pharmatest (Finland) (FI)
- UCB Pharma (Belgium) (BE)
Publication Details
- Journal
- Scandinavian Journal of Rheumatology
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1080/03009742.2025.2576962
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00